• United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 common shares at $146.03 on June 16, 2026.
• Rothblatt sold 9,500 common shares the same day at weighted-average prices ranging from $545.18 to $554.63.
• Directly held common shares fell to 40,513 following the transactions.
• Rothblatt directly held 21,910 stock options following the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000080), on June 17, 2026, and is solely responsible for the information contained therein.